$RIOT
Riot Platforms, Inc. Stock $riot

$riot Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000107997312000865 Filed on November 07, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q3
Revenue	$2.000K	$6.000K	$22.00K
YoY Change	-95.56%	-72.73%	-72.5%
Cost Of Revenue	$0.00		$382.00
YoY Change			-99.75%
Gross Profit	$1.000K	$6.000K	$22.00K
YoY Change	-97.73%	-72.73%	-131.43%
Gross Profit Margin	50.0%	100.0%	100.0%
Selling, General & Admin	$1.240M	$1.346M	$1.406M
YoY Change	2.48%	-4.24%	-27.15%
% of Gross Profit	124000.0%	22439.85%	6390.81%
Research & Development	$1.220M	$1.066M	$1.645M
YoY Change	-5.43%	-35.2%	58.17%
% of Gross Profit	122000.0%	17766.12%	7477.25%
Depreciation & Amortization	$100.0K	$91.00K	$98.00K
YoY Change	-16.67%	-7.14%	-18.33%
% of Gross Profit	10000.0%	1516.67%	445.45%
Operating Expenses	$2.440M	$2.412M	$3.051M
YoY Change	-2.01%	-20.93%	3.07%
Operating Profit	-$2.439M	-$2.402M	-$3.011M
YoY Change	-0.29%	-20.24%	-0.62%
Interest Expense			-$50.00K
YoY Change			150.0%
% of Operating Profit
Other Income/Expense, Net	-$70.00K	-$58.46K	-$52.24K
YoY Change		11.9%
Pretax Income	-$2.500M	-$2.460M	-$3.060M
YoY Change	60.26%	-19.61%	0.33%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.504M	-$2.460M	-$3.064M
YoY Change	60.82%	-19.71%	0.46%
Net Earnings / Revenue	-125200.0%	-41000.0%	-13927.27%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.294M	-$2.563M	-$18.00M
COMMON SHARES
Basic Shares Outstanding	7.716M	7.716M
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.10M	$10.20M	$4.800M
YoY Change	202.5%	112.5%	-66.2%
Cash & Equivalents	$10.98M	$9.837M	$2.401M
Short-Term Investments	$1.200M	$400.0K	$2.400M
Other Short-Term Assets	$400.0K	$500.0K	$500.0K
YoY Change	33.33%	0.0%	400.0%
Inventory			$0.00
Prepaid Expenses
Receivables	$0.00	$3.238K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.53M	$10.69M	$5.300M
YoY Change	189.94%	101.78%	-63.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.485M	$2.560M	$2.900M
YoY Change	-11.11%	-11.72%	-9.38%
Goodwill	$387.2K	$387.2K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.602M	$1.569M	$0.00
YoY Change	-0.61%
Total Long-Term Assets	$4.086M	$4.129M	$4.700M
YoY Change	-7.27%	-12.14%	-4.08%
TOTAL ASSETS
Total Short-Term Assets	$12.53M	$10.69M	$5.300M
Total Long-Term Assets	$4.086M	$4.129M	$4.700M
Total Assets	$16.61M	$14.82M	$10.00M
YoY Change	90.37%	48.24%	-48.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$613.9K	$642.0K	$1.500M
YoY Change	5.54%	-57.2%	50.0%
Accrued Expenses	$642.1K	$658.9K	$1.300M
YoY Change	74.28%	-49.32%	116.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.300M	$2.600M	$400.0K
YoY Change	109.09%	550.0%	300.0%
Total Short-Term Liabilities	$4.079M	$4.298M	$3.300M
YoY Change	96.87%	30.25%	32.0%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$800.0K	$2.500M
YoY Change	-71.43%	-68.0%	-3.85%
Other Long-Term Liabilities	$1.100M	$1.000M	$600.0K
YoY Change		66.67%	-14.29%
Total Long-Term Liabilities	$1.900M	$1.800M	$3.100M
YoY Change	-32.14%	-41.94%	-6.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.079M	$4.298M	$3.300M
Total Long-Term Liabilities	$1.900M	$1.800M	$3.100M
Total Liabilities	$5.924M	$6.061M	$6.400M
YoY Change	20.85%	-5.29%	12.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$74.23M	-$71.73M
YoY Change	14.17%
Common Stock	$84.92M	$80.49M
YoY Change	23.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.69M	$8.762M	$3.600M
YoY Change
Total Liabilities & Shareholders Equity	$16.61M	$14.82M	$10.00M
YoY Change	90.37%	48.24%	-48.45%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q3
OPERATING ACTIVITIES
Net Income	-$2.504M	-$2.460M	-$3.064M
YoY Change	60.82%	-19.71%	0.46%
Depreciation, Depletion And Amortization	$100.0K	$91.00K	$98.00K
YoY Change	-16.67%	-7.14%	-18.33%
Cash From Operating Activities	-$1.890M	-$540.0K	-$2.060M
YoY Change	-1.56%	-73.79%	-2.83%
INVESTING ACTIVITIES
Capital Expenditures	-$60.00K	-$50.00K	-$50.00K
YoY Change	0.0%	0.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	-$770.0K	-$180.0K	-$1.440M
YoY Change	-155.4%	-87.5%	3.6%
Cash From Investing Activities	-$830.0K	-$230.0K	-$1.490M
YoY Change	-162.41%	-84.56%	2.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.850M	-350.0K	-150.0K
YoY Change	234.78%	133.33%	400.0%
NET CHANGE
Cash From Operating Activities	-1.890M	-540.0K	-2.060M
Cash From Investing Activities	-830.0K	-230.0K	-1.490M
Cash From Financing Activities	3.850M	-350.0K	-150.0K
Net Change In Cash	1.130M	-1.120M	-3.700M
YoY Change	101.79%	-69.73%	2.78%
FREE CASH FLOW
Cash From Operating Activities	-$1.890M	-$540.0K	-$2.060M
Capital Expenditures	-$60.00K	-$50.00K	-$50.00K
Free Cash Flow	-$1.830M	-$490.0K	-$2.010M
YoY Change	-1.61%	-75.62%	-2.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q3	appy	Additional Milestone Maximum Payments AdditionalMilestoneMaximumPayments	2000000	USD
CY2012Q3	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	7716480
CY2011Q3	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1340649
	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1340649
	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	3772228
	appy	Cumulative Realized Loss On Marketable Securities Maximum CumulativeRealizedLossOnMarketableSecuritiesMaximum	5000	USD
CY2012Q3	appy	Deferred Revenue Net DeferredRevenueNet	1031730	USD
CY2012Q3	appy	License Agreement Maximum Milestone Payments LicenseAgreementMaximumMilestonePayments	1100000	USD
CY2012Q3	appy	License And Milestone Payments Revenue LicenseAndMilestonePaymentsRevenue	1104000	USD
	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	8193	USD
	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	2576	USD
CY2012Q3	appy	Maximum Percentage Of Any Individual Short Term Marketable Securities In Investment Portfolio MaximumPercentageOfAnyIndividualShortTermMarketableSecuritiesInInvestmentPortfolio	0.05
CY2012Q3	appy	Nonrefundable Option Payment NonrefundableOptionPayment	204000	USD
	appy	Number Of Officers Under Employement Agreements NumberOfOfficersUnderEmployementAgreements	4
CY2012Q3	appy	Other Other Long Term Assets OtherOtherLongTermAssets	5384	USD
CY2011Q4	appy	Other Other Long Term Assets OtherOtherLongTermAssets	9665	USD
CY2012Q3	appy	Percentage Of Investment Portfolio Cash And Cash Equivalent PercentageOfInvestmentPortfolioCashAndCashEquivalent	0.95
	appy	Stockholders Equity Note Reverse Stock Split Conversion Ratio StockholdersEquityNoteReverseStockSplitConversionRatio	6
CY2011Q3	appy	Weighted Average Number Of Shares Outstanding Pre Reverse Stock Split WeightedAverageNumberOfSharesOutstandingPreReverseStockSplit	8028321
	appy	Weighted Average Number Of Shares Outstanding Pre Reverse Stock Split WeightedAverageNumberOfSharesOutstandingPreReverseStockSplit	8028321
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Period End Date DocumentPeriodEndDate	2012-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001167419
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-53297	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-4490	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	231000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	102952	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44554	USD
CY2012Q3	us-gaap	Assets Assets	14823696	USD
CY2011Q4	us-gaap	Assets Assets	8727845	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	10694271	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	4321044	USD
CY2012Q3	us-gaap	Capital Capital	6393000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9836750	USD
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7716480
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	AspenBio Pharma, Inc.
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	642030	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	581713	USD
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3238	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35016	USD
CY2012Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	658888	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	368406	USD
CY2012Q3	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	-271780	USD
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3002911	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2725981	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2968104	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8908080	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2400866	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6507214	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6868646	USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7716480
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1608146
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7716480
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1608146
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	80491443	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	68846796	USD
	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Reclassifications:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain prior period amounts in the accompanying financial statements have been reclassified to conform to the presentation used in 2012.</div> <!--EndFragment--></div> </div>
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold		USD
CY2011Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	382	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15958	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	196	USD
CY2012Q3	us-gaap	Deferred Revenue DeferredRevenue	1036220	USD
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	63444	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		USD
CY2012Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	968286	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		USD
	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	1308000	USD
CY2012Q3	us-gaap	Depreciation Depreciation	91000	USD
CY2011Q3	us-gaap	Depreciation Depreciation	98000	USD
	us-gaap	Depreciation Depreciation	300000	USD
	us-gaap	Depreciation Depreciation	277000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	371008	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	334715	USD
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.29
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.46
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.78
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-171813	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	276062	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1036220	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-315388	USD
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	323684	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47622	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1176559	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1214748	USD
	us-gaap	Finite Lived Intangible Assets Useful Life FiniteLivedIntangibleAssetsUsefulLife	197
	us-gaap	Future Amortization Expense After Year Five FutureAmortizationExpenseAfterYearFive	72000	USD
	us-gaap	Future Amortization Expense Year Five FutureAmortizationExpenseYearFive	72000	USD
	us-gaap	Future Amortization Expense Year Four FutureAmortizationExpenseYearFour	72000	USD
	us-gaap	Future Amortization Expense Year One FutureAmortizationExpenseYearOne	72000	USD
	us-gaap	Future Amortization Expense Year Three FutureAmortizationExpenseYearThree	72000	USD
	us-gaap	Future Amortization Expense Year Two FutureAmortizationExpenseYearTwo	72000	USD
CY2012Q3	us-gaap	Goodwill Goodwill	387239	USD
CY2011Q4	us-gaap	Goodwill Goodwill	387239	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	6240	USD
CY2011Q3	us-gaap	Gross Profit GrossProfit	21999	USD
	us-gaap	Gross Profit GrossProfit	159061	USD
	us-gaap	Gross Profit GrossProfit	40560	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	325647	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	60317	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70437	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-31778	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	261442	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	290482	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-125901	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-185192	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-330318	USD
	us-gaap	Interest Paid InterestPaid	139004	USD
	us-gaap	Interest Paid InterestPaid	187885	USD
CY2012Q3	us-gaap	Investments And Cash InvestmentsAndCash	10226000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1020049	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	706135	USD
CY2012Q3	us-gaap	Liabilities Liabilities	6061288	USD
CY2011Q4	us-gaap	Liabilities Liabilities	4901967	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14823696	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8727845	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4298225	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2071926	USD
	us-gaap	License Costs LicenseCosts	612000	USD
CY2012Q3	us-gaap	Licenses Revenue LicensesRevenue	4490	USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	17766	USD
	us-gaap	Licenses Revenue LicensesRevenue	53297	USD
	us-gaap	Licenses Revenue LicensesRevenue	4490	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	558000	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	357000	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	71000	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	68000	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	66000	USD
CY2012Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2285000	USD
CY2012Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	794777	USD
CY2011Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2830041	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1037	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-82	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-8785	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1329	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-374021	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9958607	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	281570	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	512065	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6414763	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3602026	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-2460087	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-3063450	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8656576	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6708117	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	454830	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	480635	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-58459	USD
CY2011Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-52241	USD
CY2012Q3	us-gaap	Notes Payable NotesPayable	3404956	USD
CY2011Q4	us-gaap	Notes Payable NotesPayable	3904226	USD
CY2012Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2610179	USD
CY2011Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1074185	USD
	us-gaap	Officers Compensation OfficersCompensation	880000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	2412358	USD
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	3050974	USD
	us-gaap	Operating Expenses OperatingExpenses	8743033	USD
	us-gaap	Operating Expenses OperatingExpenses	6567975	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2401628	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3011209	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8530675	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6522925	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1569182	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1611652	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	174867	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	59869	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83201	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42024	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	793527	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	598775	USD
CY2012Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	465117	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	314800	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10938512	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1333165	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1212733	USD
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5563154	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5521130	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2560243	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2795149	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	374021	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	979905	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1065967	USD
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1644995	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4373325	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2623195	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71729035	USD
	us-gaap	Royalty Expense RoyaltyExpense	20000	USD
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6240	USD
CY2011Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22381	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	175019	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	40756	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65020918	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1346391	USD
CY2011Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1405979	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4369708	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3944780	USD
CY2012Q3	us-gaap	Short Term Investments ShortTermInvestments	389166	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	1003124	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	8762408	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	3825878	USD
CY2011Q3	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1340649
	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1340649

Files In Submission

Name	View Source	Status
0001079973-12-000865-index-headers.html	Edgar Link	pending
0001079973-12-000865-index.html	Edgar Link	pending
0001079973-12-000865.txt	Edgar Link	pending
0001079973-12-000865-xbrl.zip	Edgar Link	pending
appy-20120930.xml	Edgar Link	completed
appy-20120930.xsd	Edgar Link	pending
appy-20120930_cal.xml	Edgar Link	unprocessable
appy-20120930_def.xml	Edgar Link	unprocessable
appy-20120930_lab.xml	Edgar Link	unprocessable
appy-20120930_pre.xml	Edgar Link	unprocessable
appy_10q-093012.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RIOT
Riot Platforms, Inc. Stock $riot

2012 Q4 Form 10-Q Financial Statement

#000107997312000865 Filed on November 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT Riot Platforms, Inc. Stock $riot

2012 Q4 Form 10-Q Financial Statement

#000107997312000865 Filed on November 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT
Riot Platforms, Inc. Stock $riot